Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CLARA: A Phase 1/2 Multi-center, Randomized, Double-Masked, Prospective, Parallel-Arm Study of AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction (ABA-1)

NCT06041256 is registered in ClinicalTrials.gov with Aurion Biotech as lead sponsor.

NCT NCT06041256
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06041256 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CLARA: A Phase 1/2 Multi-center, Randomized, Double-Masked, Prospective, Parallel-Arm Study of AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction (ABA-1)
Lead sponsor
Aurion Biotech
Phase
Phase 1/2
Overall status
Completed
Start date
October 18, 2023
Completion date
April 15, 2025
Enrollment
97 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

corneal edema, corneal endothelial dysfunction